Write in a clean editor, then format for Thrombosis Journal in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Thrombosis Journal is a peer-reviewed journal published by BMC (BioMed Central), covering Venous Thromboembolism Diagnosis and Management, Blood Coagulation and Thrombosis Mechanisms, Atrial Fibrillation Management and Outcomes. Over its lifetime it has published 1,087 papers, which have received 19,662 citations.
| Publisher | BMC (BioMed Central) |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Thrombosis Journal. 2023;12(3):45–58.
Formats any DOI in Thrombosis Journal style. No sign-up. |
| Publishes research in | Venous Thromboembolism Diagnosis and Management Blood Coagulation and Thrombosis Mechanisms Atrial Fibrillation Management and Outcomes Heparin-Induced Thrombocytopenia and Thrombosis Platelet Disorders and Treatments |
| ISSN | 1477-9560 |
| Citation impact (2-yr) | 2.36 |
| h-index | 63 |
| i10-index | 484 |
| Article processing charge | $2,318 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Capital Medical University |
| Journal website | link.springer.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
BACKGROUND: Standard treatment for venous thromboembolism (VTE) consists of a heparin combined with vitamin K antagonists. Direct oral anticoagulants have been investigated for acute and extended treatment of symptomatic VTE; their use could avoid parenteral treatment and/or laboratory monitoring of anticoagulant effects. METHODS: A prespecified pooled analysis of the EINSTEIN-DVT and EINSTEIN-PE studies compared the…
BACKGROUND: Thrombolytic drugs are widely used for the management of cerebral venous sinus thrombosis patients. Several in vitro models have been developed to study clot lytic activity of thrombolytic drugs, but all of these have certain limitations. There is need of an appropriate model to check the clot lytic efficacy of thrombolytic drugs. In the…
Inflammatory diseases have become increasingly prevalent with industrialization. To address this, numerous anti-inflammatory agents and molecular targets have been considered in clinical trials. Among molecular targets, protease-activated receptors (PARs) are abundantly recognized for their roles in the development of chronic inflammatory diseases. In particular, several inflammatory effects are directly mediated by the sensing of proteolytic…
Thrombophilia can be defined as a predisposition to form clots inappropriately. Thrombotic events during infancy and childhood are increasingly recognized as a significant source of mortality and morbidity. The predisposition to form clots can arise from genetic factors, acquired changes in the clotting mechanism, or, more commonly, an interaction between genetic and acquired factors. Since…
Disseminated intravascular coagulation (DIC) is a serious disease that, in the presence of underlying disease, causes persistent, generalized, marked coagulation activation. Early treatment based on an appropriate diagnosis is very important for improving patients' prognosis, to which end diagnostic criteria play a key role. Several criteria have been proposed, but each has its strengths and…
